Patents for A61P 35 - Antineoplastic agents (221,099)
10/2008
10/15/2008EP1272515B1 Immunoregulator
10/15/2008EP1242456B1 Scfv antibodies against disease associated molecules
10/15/2008EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
10/15/2008EP1200116B1 USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
10/15/2008EP1045906B1 Apo-2 ligand
10/15/2008EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders
10/15/2008EP0915708B1 Immunogenic composition comprising tumor associated antigen and human cytokine
10/15/2008CN101287831A T-cell receptor and nucleic acid encoding the receptor
10/15/2008CN101287764A Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38
10/15/2008CN101287753A Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target
10/15/2008CN101287737A Pentacyclic kinase inhibitors
10/15/2008CN101287734A 2-氨基-7,8-二氢-6H-吡啶并[4,3-d]嘧啶-5-酮 2-amino-7,8-dihydro--6H- pyrido [4,3-d] pyrimidin-5-one
10/15/2008CN101287733A Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities
10/15/2008CN101287725A DNA-PK inhibitors
10/15/2008CN101287724A Solid salt forms of a pyrrole substituted 2-indolinone
10/15/2008CN101287712A Heterocyclic compounds
10/15/2008CN101287492A Anti-glypican-3 antibody
10/15/2008CN101287481A A pharmaceutical composition useful for the treatment of hepatocellular carcinoma
10/15/2008CN101287476A Scavenger of harmful active oxygen and/or free radical in living body
10/15/2008CN101287475A Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
10/15/2008CN101287474A Therapeutic protocols using hyaluronan
10/15/2008CN101287469A Regimen of administration for 5-(2-chlorophenyl)-1 ,2-dihydro-7-fluoro-8-methoxy-3-methyl-pyrazolo [3, 4.-b] [1, 4] benzodiazepine
10/15/2008CN101287463A New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders
10/15/2008CN101287454A Iontophoresis preparation for treatment of breast cancer and/or mastitis
10/15/2008CN101287452A Solid pharmaceutical compositions comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl) phthalazine and a ph modifier
10/15/2008CN101284873A Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2008CN101284861A Triterpenoid saponin compounds, preparation method and use
10/15/2008CN101284860A Antineoplastic pharmaceutical compositions, preparation method and applications thereof
10/15/2008CN101284859A Panaxadiol saponin microbial conversion hydrolysate and method for preparing same
10/15/2008CN101284853A Carbohydrate derivates, transient metal complex compounds, method for preparing same and use on treating cancer
10/15/2008CN101284835A Dimeric sesquiterpene lactone compounds, preparation method and applications thereof
10/15/2008CN101284834A Bi-inulicin 1, preparation method and applications thereof
10/15/2008CN101284833A Bi-inulicin 4, preparation method and applications thereof
10/15/2008CN101284827A Antineoplastic compounds containing triazole ring naphthoyl imines and method for preparing same
10/15/2008CN101284820A Amino peptidase inhibiting substance and synthetic method
10/15/2008CN101284792A Bisbenzylisoquinoline compounds, preparation method and applications
10/15/2008CN101284133A Drug carried target cationic polymer for injections and modified by integrin ligand
10/15/2008CN101284127A Injection for curing angiomatous
10/15/2008CN101284120A Process for preparing Pingxiao preparation
10/15/2008CN101284118A Qiankun Yilidan pellet
10/15/2008CN101284116A Chinese medicine capsules for curing digestive system tumor
10/15/2008CN101284107A Medicine for curing cancers and preparation method thereof
10/15/2008CN101284095A Anti-cancer Chinese medicine
10/15/2008CN101284056A Drug for curing rectal cancer
10/15/2008CN101284052A Chinese medicinal materials compound prescription for treating the tumor
10/15/2008CN101284032A Delicate fragrance vine formulations and preparation method thereof
10/15/2008CN101284018A Medicine for treating mammary cancer
10/15/2008CN101284008A IL-4R antagonist and microorganism for generating the IL-4R antagonist
10/15/2008CN101284007A Pharmaceutical use of aryl group substituted pyridone derivates
10/15/2008CN101284005A Application of indirubin for preparing medicine for preventing blood vessel from regenerating
10/15/2008CN101284004A Application of two bi-sesquiterpenes compound for preparing antineoplastic and antiinflammatory medicine
10/15/2008CN101283998A Application of bromine phenolic compound in preparing the medicine for curing the malignancy
10/15/2008CN101283995A Different pharmaceutical uses alpha2delta ligands
10/15/2008CN101283983A Stable camptothecine liposome composition
10/15/2008CN101283978A Anticancer sustained-release gel injection containing platinum compound
10/15/2008CN101283977A Sustained-release gel injection loaded with platinum compound and alkyl agent
10/15/2008CN101283976A Anticancer sustained-release gel injection containing taxone medicine
10/15/2008CN101283975A Anticancer sustained-release gel injection containing neonatal blood vessel inhibitor
10/15/2008CN101283974A Anticancer sustained-release gel injection and preparation method thereof
10/15/2008CN101283822A Functionality beverage containing burdock and preparation method thereof
10/15/2008CN101283715A Health-care beverage health preservation tea
10/15/2008CN100425700C scFvC6.5-sTrail fusion gene and protein, and its preparation
10/15/2008CN100425699C scFvC6.5-TNF-alpha fusion gene and protein, and its preparation
10/15/2008CN100425697C Nucleotid sequence of human interleukin 21 and method and application of producing matured human interleukin 21
10/15/2008CN100425695C Novel human Rab GTP enzyme, its coding sequence and application
10/15/2008CN100425621C Steroid imidazole salt compound and its preparing process
10/15/2008CN100425608C Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/15/2008CN100425600C Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as CDC25 phosphatase inhibitors
10/15/2008CN100425592C Indole derivatives
10/15/2008CN100425290C CCA gene vaccine, and its establishing method and use for preparing vaccine for preventing and treating tumour
10/15/2008CN100425289C Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin
10/15/2008CN100425287C Tumor vaccines
10/15/2008CN100425284C Methods for glucagon suppression
10/15/2008CN100425252C Medicine for treating leukopenia
10/15/2008CN100425247C Refining ganoderam lucidum spore oil and method for preparing same
10/15/2008CN100425244C Aluminium sulfate for injection and aluminium sulfate injection for treating bladder tumor
10/15/2008CN100425240C Use of the quinazoline derivative ZD6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeabi
10/14/2008US7435832 Preparing an anhydrous crystal of a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide by reacting the acid and amine in a solvent and crystallizing under various process conditions
10/14/2008US7435820 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use
10/14/2008US7435806 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences
10/14/2008US7435797 Anti-HER2 antibody variants
10/14/2008US7435754 Laulimalide microtubule stabilizing agents
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435739 Antiproliferative agents; skin, prostate glands, kidneys, central nervous system
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008US7435726 Thalidomide and a topoisomerase inhibitor anticancer drug such as irinotecan; reduces toxicity related side effects of anticancer drug
10/14/2008US7435595 Using prokaryotic histone protein as tool in transfer of heterologus nucleotide sequences into cells; improving exogenous gene expression
10/14/2008US7435585 Auto-stimulating cells and methods for making and using the same
10/14/2008US7435554 Immunoglobulin specific to lung cancer cell surface protein for use as tool in detection and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics; antitumor agents
10/14/2008US7435415 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
10/14/2008CA2387727C Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
10/14/2008CA2379995C 11.beta.-aryl-17,17-spirothiolane-substituted steroids
10/14/2008CA2338801C Tin polyoxaalkanecarboxylates and compositions containing them
10/14/2008CA2279279C Lipid complexes and liposomes of highly insoluble platinum complexes
10/14/2008CA2275351C Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
10/14/2008CA2255865C Synthesis of soluble beta-sheet forming peptides
10/14/2008CA2171625C Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents